Quantcast

Latest Pneumococcal vaccine Stories

2010-08-23 11:01:00

NEW YORK, Aug. 23 /PRNewswire-FirstCall/ -- The World Health Organization (WHO) has granted prequalification to Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine. WHO prequalification allows for the...

2010-07-22 13:17:19

The GAVI Alliance and Johns Hopkins Bloomberg School of Public Health celebrate new vaccine era; applaud Baltimore's efforts to immunize every child; call for resources to do the same worldwide A Johns Hopkins University scientist, whose team of researchers recently identified pneumonia, diarrhea, and malaria as the primary causes of death of 6 million of the world's poorest children, today called on leaders in donor and developing nations to take action to address the terrible death toll....

2010-07-18 23:01:00

PHILADELPHIA, July 19 /PRNewswire-USNewswire/ -- A pneumococcal conjugate vaccine introduced in the U.S. 10 years ago appears to reduce pneumonia and serious associated complications, such as blood infections, in the vaccine's target range, children less than a year old, according to new research. However, pneumonia and associated complications, including a lung infection called empyema, increased in older children, the study found. The results also show a narrowing of racial...

2010-07-01 11:19:00

James E. Connolly Committed to Accelerating the Development of New Vaccines to Prevent Tuberculosis ROCKVILLE, Md., July 1 /PRNewswire-USNewswire/ -- The Aeras Global TB Vaccine Foundation today announced that James E. Connolly has been named President and Chief Executive Officer. He joins Aeras after a career in the pharmaceutical industry, most recently as Executive Vice President and General Manager of Wyeth Vaccines. He will take over as Aeras President and CEO on August 9, 2010....

2010-05-05 14:34:01

Kaiser Permanente used electronic health records to study 84,000 men The pneumococcal pneumonia vaccination is not associated with a reduced risk of heart attacks or strokes, according to a Kaiser Permanente study published in the Journal of the American Medical Association that followed 84,170 men aged 45 to 69. The five-year prospective cohort study provides new insights about the association between pneumococcal vaccination and heart attacks and strokes. While previous studies have shown...

2010-05-05 12:03:42

Men 45 years or older who received pneumococcal vaccine were not less likely to have a heart attack or stroke compared to men who did not receive the vaccine, according to a study in the May 5 issue of JAMA. Hung Fu Tseng, Ph.D., of Kaiser Permanente Southern California, Pasadena, and colleagues conducted a study to examine the association between vaccination with pneumococcal vaccine and the risk of developing acute heart attack and stroke in men, taking into account known and potentially...

2010-04-26 07:00:00

BETHESDA, Md., April 26 /PRNewswire/ -- Scientists at the 13th Annual Conference on Vaccine Research (ACVR), sponsored by the National Foundation for Infectious Diseases (NFID), will reflect on the remarkable growth of vaccine biotechnology in the last several decades and focus on the growing number of challenging illnesses that may become vaccine-preventable or vaccine-treatable in the coming years. According to Susan J. Rehm, MD, Medical Director for NFID, "In addition to the reality...

6e7162b3a67fdb3e70536f315ba00a2d1
2010-03-24 07:08:57

Two of the largest pharmaceutical companies in the world have agreed to a 10-year commitment to supply new pneumonia vaccines to developing nations across the globe. The Global Alliance for Vaccines and Immunization (GAVI) announced Tuesday that GlaxoSmithKline (GSK) and Pfizer, Inc. became the first two firms to support a plan that would ensure infants and children in poor countries would receive the pneumococcal vaccine for a reduced fee. Each company has committed to supply 30 million...

2010-03-23 09:00:00

LONDON, March 23 /PRNewswire-FirstCall/ -- GSK (NYSE: GSK) has become one of the first manufacturers to sign a unique agreement with the GAVI Alliance (GAVI) that has the potential to save millions of children from dying in the world's poorest countries. GSK will supply up to 300 million doses of its vaccine Synflorix, for invasive pneumococcal disease, to GAVI over a ten year period. Pneumococcal disease is a leading cause of death in children under the age of five in developing...

a870a9d79c52fbf131bdec62a1e422d51
2010-03-15 14:35:00

The Global Alliance on Vaccines and Immunization (GAVI) said on Monday that a further 4.3 billion dollars is needed if the global vaccines alliance is to meet its goal of supplying life-saving immunizations to millions of children in poor countries by 2015. The GAVI Alliance invited existing and potential donors to a meeting on March 25 and 26 in The Hague to ask them to "make a strong impact" on childhood death rates. According to Reuters, world leaders from 189 countries signed up in...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related